Li M, Guan H, Zhong M, Di X, et al. Willingness to Switch to Long-Acting Injectable Cabotegravir and Rilpivirine Every 2 Months for People Living with HIV in Nanjing, China. AIDS Res Hum Retroviruses 2024 Dec 12. doi: 10.1089/aid.2023.0150.
PMID: 39665580